Volume 15, Number 11—November 2009
Hybrid El Tor Vibrio cholerae O1, Kuwait
Highlight and copy the desired format.
|EID||Joshi RM, Albert M. Hybrid El Tor Vibrio cholerae O1, Kuwait. Emerg Infect Dis. 2009;15(11):1879-1880. https://dx.doi.org/10.3201/eid1511.090357|
|AMA||Joshi RM, Albert M. Hybrid El Tor Vibrio cholerae O1, Kuwait. Emerging Infectious Diseases. 2009;15(11):1879-1880. doi:10.3201/eid1511.090357.|
|APA||Joshi, R. M., & Albert, M. (2009). Hybrid El Tor Vibrio cholerae O1, Kuwait. Emerging Infectious Diseases, 15(11), 1879-1880. https://dx.doi.org/10.3201/eid1511.090357.|
To the Editor: The traditional causative agent of cholera, Vibrio cholerae O1, has 2 biotypes, classical and El Tor. The current seventh pandemic that began in 1961 and has spread to much of the world is caused by the El Tor biotype. This biotype has replaced the classical biotype responsible for the previous pandemics. The classical and El Tor biotypes are differentiated by phenotypic tests (1), and several nucleotide base differences occur at positions 115 and 203 in the ctxB gene (C in both positions in the classical and T in both positions in the El Tor biotype). These differences translate to histidine at amino acid position 39 and threonine at amino acid position 68 for the B subunit of cholera toxin (CT) in the classical biotype and tyrosine and isoleucine, respectively, for the corresponding amino acids in the El Tor biotype (2).
Recently, 3 variants of the El Tor biotype have been found. These are the Matlab variants, which could not be biotyped because they have a mixture of classical and El Tor traits (1); the Mozambique variant, which has a typical El Tor genome but a tandem repeat of the classical CTX prophage located in the small chromosome (3); and the hybrid El Tor variant, which has a typical El Tor biotype and an El Tor CTX prophage but produces CT of the classical type (4).
This hybrid El Tor variant has replaced the El Tor biotype in Dhaka and other parts of Bangladesh (4) and in India (5), Japan, Hong Kong, Zambia, the People’s Republic of China, Sri Lanka, and Vietnam (6). Kuwait was affected by cholera in the mid 1960s during the current seventh pandemic. Subsequently, cholera disappeared from Kuwait as living standards improved. Screening of ≈5,000 acute-phase diarrheal stool samples in the mid-1980s in a major hospital in Kuwait did not yield V. cholerae O1 (7). The occasional cholera cases detected in Kuwait are imported, mainly from Asia through expatriate workers.
Two adult men, one who had just arrived from India and one who had just arrived from the Philippines, were admitted with severe watery diarrhea, vomiting, and dehydration to the Al-Adan Hospital, Kuwait, in November and December 2008, respectively. The patient from India reported eating in restaurants, and the patient from the Philippines had consumed fish soup just before the journey. Both patients were initially rehydrated with intravenous fluids.
Stool cultures were performed by using a battery of media, including thiosulfate citrate bile salt sucrose (TCBS) agar. Yellow colonies from TCBS agar were tested by using MicroScan WalkAway 96 (Dade Behring, West Sacramento, CA, USA) panel NBPC 34 and API 20E strip (bioMérieux, Marcy l’Etoile, France), which suggested V. cholerae. In slide agglutination tests, the colonies agglutinated with V. cholerae O1 polyvalent antiserum and Ogawa serotype antiserum (Denka-Seiken, Tokyo, Japan). The isolate from the patient from India was susceptible to tetracycline and ampicillin and resistant to co-trimoxazole, but the isolate from the patient from the Philippines was susceptible to all 3 of these antimicrobial agents in MicroScan (Dade Behring) and disk diffusion tests. Both patients were successfully treated with rehydration therapy and intravenous vibramycin (a semisynthetic tetracycline). Both V. cholerae O1 Ogawa isolates showed positive results in Vogues-Proskauer, chicken cell agglutination, and tube hemolysin tests and were resistant to polymyxin B (50 international units), results that suggest the El Tor biotype (1).
Both isolates were positive for the ctxA gene and El Tor–specific tcp gene but negative for classical-specific tcp gene by PCR (8). The genotype of the ctxB gene was determined by a mismatch amplification mutation assay PCR that detects polymorphism at nucleotide position 203; both isolates yielded a 186-bp amplicon with the classical biotype-specific primers and no amplicon with the El Tor biotype-specific primers (9).
The classical ctxB genotype of the isolates was further confirmed by sequencing the ctxB gene by using the BigDye termination method (Applied Biosystems, Foster City, CA, USA) with specific primers (10). This sequencing showed that both isolates had histidine at position 39 and threonine at position 68 in CT-B subunit. Thus, the isolates are hybrid variants that are phenotypically El Tor but genotypically classical for the ctxB gene.
Our findings suggest that cholera caused by the hybrid variant is present in the Philippines. The 2 cholera cases reported here were imported into Kuwait by travelers from cholera-endemic regions and were not endemic illnesses. The hybrid variant could possibly initiate the next cholera pandemic. Also, because CT is related to the major clinical sign of the disease, genetic changes in the molecule could result in alteration in the manifestation of the disease. The changes could also influence the effectiveness of cholera vaccines that contain CT-B as a component (6).
- Nair GB, Faruque SM, Bhuiyan NA, Kamruzzaman M, Siddique AK, Sack DA. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol. 2002;40:3296–9.
- Popovic T, Fields PI, Olsvik O. Detection of cholera toxin genes. In: Wachsmuth IK, Blake PA, Olsvik O, editors. Vibrio cholerae and cholera: molecular to global perspectives. Washington: American Society for Microbiology; 1994. p. 41–52.
- Faruque SM, Tam VC, Chowdhury N, Diraphat P, Dziejman M, Heidelberg JF, Genomic analysis of the Mozambique strains of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. Proc Natl Acad Sci U S A. 2007;104:5151–6.
- Nair GB, Qadri F, Holmgren J, Svennerholm A-M, Safa A, Bhuiyan NA, Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. J Clin Microbiol. 2006;44:4211–3.
- Nair GB, Mukhopadhyay AK, Safa A, Takeda Y. Emerging hybrid variants of Vibrio cholerae O1. In: Faruque SM, Nair GB, editors. Vibrio cholerae: genomics and molecular biology. Norfolk (UK): Caister Academic Press; 2008. p. 179–90.
- Safa A, Sultana J, Cam PD, Mwansa JC, Kong RYC. Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa. Emerg Infect Dis. 2008;14:987–8.
- Dhar R, Ghafoor MA, Nasralah AY. Unusual non-serogroup O1 Vibrio cholerae bacteremia associated with liver disease. J Clin Microbiol. 1989;27:2853–5.
- Sharma C, Thungapathra M, Ghosh A, Mukhopadhyay AK, Basu A, Mitra R, Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India. J Clin Microbiol. 1998;36:756–63.
- Morita M, Ohnishi M, Arakawa E, Bhuiyan NA, Nusrin S, Alam M, Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiol Immunol. 2008;52:314–7.
- Olsvik O, Wahlberg J, Petterson B, Uhlen M, Popovic T, Wachsmuth IK, Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol. 1993;31:22–5.
Please use the form below to submit correspondence to the authors or contact them at the following address:
M. John Albert, Department of Microbiology, Faculty of Medicine, Kuwait University, PO Box 24923, Safat 13110, Kuwait
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 09, 2010
- Page last updated: December 09, 2010
- Page last reviewed: December 09, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)